Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?-Reference-Cited by-同舟云学术

Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?

Published:2018-04 Issue: Volume:93 Page:127-137
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Minicozzi Pamela^ORCID,Walsh Paul M.,Sánchez Maria-José,Trama Annalisa,Innos Kaire,Marcos-Gragera Rafael,Dimitrova Nadya,Botta Laura,Johannesen Tom B.,Rossi Silvia,Sant Milena

Funder

Compagnia di San Paolo

Cariplo Foundation

European Commission

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. P. Minicozzi, R. Otter, M. Primic-Žakelj and S. Francisci, (Eds.), Survival of cancer patients in Europe, 1999–2007: the EUROCARE-5 study, Eur J Cancer vol. 51, 2015, 2099–2268.

2. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study;De Angelis;Lancet Oncol,2014

3. Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands;Visser;Eur J Cancer,2005

4. High resolution studies,2017

5. Variation in ‘standard care’ for breast cancer across Europe: a EUROCARE-3 high resolution study;Allemani;Eur J Cancer,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hawthorn with “homology of medicine and food”: a review of anticancer effects and mechanisms;Frontiers in Pharmacology;2024-06-10

2. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population‐based study in Italy;International Journal of Cancer;2024-03-23

3. Patterns of care and survival for lung cancer: Results of the European population-based high-resolution study;Frontiers in Epidemiology;2023-03-03

4. Perspectives for Cancer Care and Research in Central and Eastern Europe;Oncology Research and Treatment;2022-12-02

5. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000–2014 in 59 countries (CONCORD-3);British Journal of Dermatology;2022-09-01